Events

Here are the upcoming Resolian events.

 

October 2024
Oct
20
  • Bioanalytical
  • Exhibiting
8:30 am - 1:30 pm
Join us at AAPS 2024. Booth #1610 PharmSci 2024 brings together leading researchers from academia and industry. You will hear about the latest in cutting edge science....
November 2024
Nov
17
  • Bioanalytical
  • Exhibiting
All day
American College of Toxicology. 45th Annual Meeting (2024) 📍 Booth  208   The Annual Meeting is the heart of ACT. Our November gathering brings together a...
Nov
20
  • Bioanalytical
  • Exhibiting
All day
"Taking the temperature of Bioanalysis" Join us at EBF 2024 Booth B9 Our Presentations Jack Hodges "Agile development and Risk-Based validation of bespoke LIMS – Laboratory...
Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.